Turati Marco, Franchi Silvia, Crippa Marco, Rizzi Laura, Rigamonti Luca, Sacerdote Paola, Gatti Simone Daniel, Piatti Massimiliano, Galimberti Giulia, Munegato Daniele, Amodeo Giada, Omeljaniuk Robert J, Zatti Giovanni, Torsello Antonio, Bigoni Marco
Orthopedic Department, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
J Clin Med. 2023 Jun 28;12(13):4330. doi: 10.3390/jcm12134330.
Knee osteoarthritis (OA) is a chronic degenerative inflammatory-based condition caused by a cascade of different intra-articular molecules including several cytokines. Among the cytokines, prokineticins (PKs) have recently been identified as important mediators of inflammation and pain. This observational study examined the potential involvement of PK2 in degenerative or traumatic knee disease. Fifteen patients presenting knee osteoarthritis (OA group) and 15 patients presenting a traumatic meniscal tear (TM group) were studied. Synovial fluid samples from affected knees were assessed for PK2, IL-10, and TNF-α using the ELISA method. At a long-term follow-up (minimum 5 years, mean = 6.1 years), patients in the TM group underwent clinical re-evaluation with PROMs (Tegner Activity Scale, IKDC, Lysholm, SKV); in addition, X-ray visualization was used to assess the presence of secondary OA. PK2 was detected in synovial fluids of both TM and OA patients and the levels were comparable between the two groups, while IL-10 levels were significantly greater in the OA group than those in TM patients. PK2 levels correlated with those of IL-10. PK2 levels were greater in blood effusions compared to clear samples, did not differ significantly between sexes, nor were they related to differences in weight, height, or injury (meniscal laterality, time since dosing). No correlation was found between PROMs and radiological classifications in patients in the TM group at final follow-up. These data are the first observations of PK2 in synovial fluid following traumatic meniscus injury. These findings suggest possible further prognostic indices and therapeutic targets to limit the development of secondary OA.
膝骨关节炎(OA)是一种基于慢性退行性炎症的病症,由包括多种细胞因子在内的一系列不同关节内分子引发。在这些细胞因子中,促动力蛋白(PKs)最近被确认为炎症和疼痛的重要介质。这项观察性研究探讨了PK2在退行性或创伤性膝关节疾病中的潜在作用。研究了15例膝骨关节炎患者(OA组)和15例创伤性半月板撕裂患者(TM组)。采用酶联免疫吸附测定(ELISA)法评估患侧膝关节滑液样本中的PK2、白细胞介素-10(IL-10)和肿瘤坏死因子-α(TNF-α)。在长期随访(最短5年,平均6.1年)中,TM组患者采用患者报告结局量表(PROMs,包括特格纳活动量表、国际膝关节文献委员会[IKDC]评分、莱霍尔姆评分、瑞典膝关节评分[SKV])进行临床重新评估;此外,通过X线显像评估继发性OA的存在情况。在TM组和OA组患者的滑液中均检测到PK2,且两组水平相当,而OA组的IL-10水平显著高于TM组患者。PK2水平与IL-10水平相关。与清亮样本相比,血性积液中的PK2水平更高,在性别之间无显著差异,也与体重、身高或损伤情况(半月板侧别、受伤时间)的差异无关。在最终随访时,TM组患者的PROMs与放射学分类之间未发现相关性。这些数据是首次对创伤性半月板损伤后滑液中PK2的观察结果。这些发现提示可能存在进一步的预后指标和治疗靶点,以限制继发性OA的发展。